This possibility appears less likely as previous studies indicate no increase in average birthweight during times of year when insulin treatment is reduced.5 Future studies that include results of continuous glucose monitoring in GDM may help to further assess detailed correlations between glycaemic control and insulin prescription. The gene discussed is INS; the disease is gestational diabetes.